AwesomeCapital
Search This Blog
Monday, September 9, 2019
PhaseBio target cut to $17 from $20 by Stifel
Maintains Buy
https://www.benzinga.com/stock/PHAS/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.